Drug Stores

The performance of the global drug retails sector is expected to decelerate, and the forecasted value of the sector in 2016 is $1,147.1 billion. Which trends are shaping today’s market? What challenges is this sector likely to face in the next five years?

Get a detailed picture of the current scenario and the future direction of the market in the publications listed under Research and Markets’ Drug Stores category. Our reports, books, and subscriptions will provide you with reliable historical data and forecasts, including key indicators such as market shares, market potential per region, number and density of outlets, retail area, number of employees, productivity indicators, and much more.

Examples of companies mentioned include the US giants Walgreens, CVS Caremark, and Rite Aid, together with hundreds of players worldwide. Show Less ... more

• Drugs & Druggists' Sundries Wholesale Lines World Report

  EURO€ 2,318.00USD$ 3,015.00GBP£ 1,950.00AUD$ 2,949.00JPY¥ 297,715.00SEK 19 798,00CHF 2'842.00CAD$ 3,073.00 PureData, May 2013 , Pages: 2070
  DRUGS & DRUGGISTS' SUNDRIES WHOLESALE LINES WORLD REPORT The Drugs & Druggists' Sundries Wholesale Lines World Report gives Market Consumption / Products / Services for over 200 countries by 6 to...

• Drugs & Druggists' Sundries Wholesalers World Report

  EURO€ 2,318.00USD$ 3,015.00GBP£ 1,950.00AUD$ 2,949.00JPY¥ 297,715.00SEK 19 798,00CHF 2'842.00CAD$ 3,073.00 PureData, May 2013 , Pages: 2020
  DRUGS & DRUGGISTS' SUNDRIES WHOLESALERS WORLD REPORT The Drugs & Druggists' Sundries Wholesalers World Report gives Market Consumption / Products / Services for over 200 countries by 6 to 10-Digit...

• General-Line Drugs Wholesale Lines World Report

  EURO€ 2,318.00USD$ 3,015.00GBP£ 1,950.00AUD$ 2,949.00JPY¥ 297,715.00SEK 19 798,00CHF 2'842.00CAD$ 3,073.00 PureData, May 2013 , Pages: 2180
  GENERAL-LINE DRUGS WHOLESALE LINES WORLD REPORT The General-Line Drugs Wholesale Lines World Report gives Market Consumption / Products / Services for over 200 countries by 6 to 10-Digit NAICS Product...

• Specialty-Line Drugs Wholesale Lines World Report

  EURO€ 2,318.00USD$ 3,015.00GBP£ 1,950.00AUD$ 2,949.00JPY¥ 297,715.00SEK 19 798,00CHF 2'842.00CAD$ 3,073.00 PureData, May 2013 , Pages: 2198
  SPECIALTY-LINE DRUGS WHOLESALE LINES WORLD REPORT The Specialty-Line Drugs Wholesale Lines World Report gives Market Consumption / Products / Services for over 200 countries by 6 to 10-Digit NAICS...

• Drugs & Druggists' Sundries Agents & Brokers Lines World Report

  EURO€ 2,318.00USD$ 3,015.00GBP£ 1,950.00AUD$ 2,949.00JPY¥ 297,715.00SEK 19 798,00CHF 2'842.00CAD$ 3,073.00 PureData, May 2013 , Pages: 2015
  DRUGS & DRUGGISTS' SUNDRIES AGENTS & BROKERS LINES WORLD REPORT The Drugs & Druggists' Sundries Agents & Brokers Lines World Report gives Market Consumption / Products / Services for over 200 countries...

• Pharmacies & Drug Stores World Report

  EURO€ 2,318.00USD$ 3,015.00GBP£ 1,950.00AUD$ 2,949.00JPY¥ 297,715.00SEK 19 798,00CHF 2'842.00CAD$ 3,073.00 PureData, May 2013 , Pages: 2088
  PHARMACIES & DRUG STORES WORLD REPORT The Pharmacies & Drug Stores World Report gives Market Consumption / Products / Services for over 200 countries by 6 to 10-Digit NAICS Product Codes by 3 Time...

• Pharmacies & Drug Store Lines World Report

  EURO€ 2,318.00USD$ 3,015.00GBP£ 1,950.00AUD$ 2,949.00JPY¥ 297,715.00SEK 19 798,00CHF 2'842.00CAD$ 3,073.00 PureData, May 2013 , Pages: 2198
  PHARMACIES & DRUG STORE LINES WORLD REPORT The Pharmacies & Drug Store Lines World Report gives Market Consumption / Products / Services for over 200 countries by 6 to 10-Digit NAICS Product Codes...

• Drug Stores

  EURO€ 99.00USD$ 129.00GBP£ 83.00AUD$ 126.00JPY¥ 12,737.00SEK 847,00CHF 122.00CAD$ 131.00 First Research, Feb 2013 , Pages: 10
  First Research is the leading industry intelligence company that helps sales teams perform faster and smarter, open doors, and close more deals. First Research performs the heavy lifting" by synthesizing...

• Arcadia Resources Inc.,(KADR) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Arcadia Resources Inc. (KADR), plus vital industry benchmarks and extensive operating ratios, along with an...

• AtCor Medical Holdings Limited,(AMDHF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AtCor Medical Holdings Limited (AMDHF), plus vital industry benchmarks and extensive operating ratios, along...

• Baxter International Inc,(BAX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Baxter International Inc (BAX), plus vital industry benchmarks and extensive operating ratios, along with...

• Atrion Corporation,(ATRI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Atrion Corporation (ATRI), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Avitar, Inc.,(AVTI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 47
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Avitar, Inc. (AVTI), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• ArQule Inc,(ARQL) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for ArQule Inc (ARQL), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

• ArthroCare Corp,(ARTC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for ArthroCare Corp (ARTC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Assurant Inc,(AIZ) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Assurant Inc (AIZ), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• AstraZeneca plc,(AZN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AstraZeneca plc (AZN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Athenahealth Inc,(ATHN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Athenahealth Inc (ATHN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Banyan Corporation,(BNYN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Banyan Corporation (BNYN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Astellas Pharma Inc,(ALPMY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Astellas Pharma Inc (ALPMY), plus vital industry benchmarks and extensive operating ratios, along with an...

• AtriCure, Inc.,(ATRC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AtriCure, Inc. (ATRC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• AxoGen Inc,(AXGN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AxoGen Inc (AXGN), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

• Arrhythmia Research Technology,(HRT) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Arrhythmia Research Technology (HRT), plus vital industry benchmarks and extensive operating ratios, along...

• Assisted Living Concepts Inc.,(ALC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Assisted Living Concepts Inc. (ALC), plus vital industry benchmarks and extensive operating ratios, along...

• Integra Lifesciences Holdings Corp,(IART) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Integra Lifesciences Holdings Corp (IART), plus vital industry benchmarks and extensive operating ratios,...

• Intraop Medical Corporation,(IOPD) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Intraop Medical Corporation (IOPD), plus vital industry benchmarks and extensive operating ratios, along with...

• Kewaunee Scientific Corp.,(KEQU) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Kewaunee Scientific Corp. (KEQU), plus vital industry benchmarks and extensive operating ratios, along with...

• Integrated Healthcare Holdings, Inc.,(IHCH) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Integrated Healthcare Holdings, Inc. (IHCH), plus vital industry benchmarks and extensive operating ratios,...

• IntriCon Corporation,(IIN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for IntriCon Corporation (IIN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Kensey Nash Corporation,(KNSY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 47
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Kensey Nash Corporation (KNSY), plus vital industry benchmarks and extensive operating ratios, along with...

• Kimberly-Clark Corp,(KCDMF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Kimberly-Clark Corp (KCDMF), plus vital industry benchmarks and extensive operating ratios, along with an...

• Kinetic Concepts Inc (KCI),(KCIAL) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Kinetic Concepts Inc (KCI) (KCIAL), plus vital industry benchmarks and extensive operating ratios, along with...

• Electromed Inc,(ELMD) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Electromed Inc (ELMD), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Eli Lilly & Company,(LLY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Eli Lilly & Company (LLY), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Five Star Quality Care, Inc.,(FVE) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Five Star Quality Care, Inc. (FVE), plus vital industry benchmarks and extensive operating ratios, along with...

• Fonar Corporation,(FONR) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Fonar Corporation (FONR), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• GlaxoSmithKline plc,(GSK) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for GlaxoSmithKline plc (GSK), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Golden Meditech,(GMDTF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Golden Meditech (GMDTF), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Catasys Inc,(CATS) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Catasys Inc (CATS), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Centene Corporation,(CNC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Centene Corporation (CNC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Commonwealth Biotechnologies, Inc.,(CBTEQ) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Commonwealth Biotechnologies, Inc. (CBTEQ), plus vital industry benchmarks and extensive operating ratios,...

• iSonea Ltd,(ISOAY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for iSonea Ltd (ISOAY), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• IsoRay, Inc.,(ISR) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for IsoRay, Inc. (ISR), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• DrugMax Inc,(FMRX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for DrugMax Inc (FMRX), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Computer Vision Systems Laboratories Corp.,(CVSL) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Computer Vision Systems Laboratories Corp. (CVSL), plus vital industry benchmarks and extensive operating...

• Cross Atlantic Commodities, Inc.,(CXAC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Cross Atlantic Commodities, Inc. (CXAC), plus vital industry benchmarks and extensive operating ratios, along...

• CSL Limited,(CMXHY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for CSL Limited (CMXHY), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Diagnostic Imaging International Corporation,(DIIG) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Diagnostic Imaging International Corporation (DIIG), plus vital industry benchmarks and extensive operating...

• Institut Straumann AG,(SAUHF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Institut Straumann AG (SAUHF), plus vital industry benchmarks and extensive operating ratios, along with an...

• Laboratory Corp of America Holdings,(LH) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Laboratory Corp of America Holdings (LH), plus vital industry benchmarks and extensive operating ratios, along...